Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice

« Previous Next »Journal of Neuroimmunology
Volume 171, Issue 1 , Pages 8-16, February 2006

Minako Oshima
- Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
- Corresponding author. Tel.: +1 713 798 6387; fax: +1 713 798 6437.
- These authors contributed equally.
Takahiro Maruta
- Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
- These authors contributed equally.
Maki Ohtani
- Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
Philip R. Deitiker
- Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
DennisR. Mosier
- Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
- Neurology and Medical Research Services, M.E. DeBakey V.A. Medical Center, Houston, TX 77030, USA
M. Zouhair Atassi
- Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
- Department of Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA